跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEFLUNOMIDA AUROVITAS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LEFLUNOMIDA AUROVITAS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
LEFLUNOMIDA AUROVITAS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Aurovitas Spain, S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 21, 2022
Approval ID
ecc61f38e761ac73
Company
Aurovitas Spain, S.A.U.
Type
Standard
Approval Details
Approval Id
ecc61f38e761ac73
Drug Cima Aemps Name
LEFLUNOMIDA AUROVITAS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
87995
Holder Company Name
Aurovitas Spain, S.A.U.
Marketing Company Name
Aurovitas Spain, S.A.U.
Authorization Date
2022-07-21
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
20 MG
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Aurovitas Spain, S.A.U.
Active Ingredients
LEFLUNOMIDA
20 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 21, 2022
Approval ID
ecc61f38e761ac73
Type
Standard
Back to CIMA-AEMPS Approvals